Case Report of a Novel Association between Anti-p200 Pemphigoid and Acquired Haemophilia A

Anti-p200 pemphigoid is an uncommon subepidermal autoimmune bullous disease that, unlike many other autoimmune bullous diseases, has not previously been associated with hematological diseases. The diagnosis of anti-p200 pemphigoid in a patient with congruent clinical features requires the demonstration of subepidermal blistering, with linear deposition of immunoglobulin (Ig) G and/or C3 at the dermoepidermal junction on direct immunofluorescence, and a floor-binding pattern on indirect immunofluorescence. In addition, the detection of antibodies against p200 antigen via immunoblotting is ideal but not readily accessible in many facilities, leading to a potential under-recognition and under-diagnosis of this condition. In this case report, we describe a 53-year-old gentleman with recently diagnosed acquired hemophilia A who developed a concurrent vesiculobullous eruption and was evaluated to have anti-p200 pemphigoid. Both of his conditions were controlled with immunosuppression via prednisolone and cyclophosphamide. While we acknowledge the contemporaneous occurrence of both diseases in this patient may be a mere coincidence, it is important to recognize the possibility of this association given the potential clinical significance. Whether the activity of one disease parallels the other will require further evaluation.

[1]  H. Ng,et al.  Bullous pemphigoid is a common associated disorder with acquired haemophilia A , 2020, International Journal of Hematology.

[2]  P. Giangrande,et al.  International recommendations on the diagnosis and treatment of acquired hemophilia A , 2020, Haematologica.

[3]  D. Zillikens,et al.  Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin. , 2019, Journal of the American Academy of Dermatology.

[4]  K. Kridin,et al.  Anti-p200 Pemphigoid: A Systematic Review , 2019, Front. Immunol..

[5]  T. Hashimoto,et al.  Pharyngeal obstruction due to hemorrhagic bullae in a patient with anti‐BP180‐type mucous membrane pemphigoid associated with acquired hemophilia A , 2019, The Journal of dermatology.

[6]  Wuttidej Fakprapai,et al.  Bullous Pemphigoid Associated with Acquired Hemophilia A: A Case Report and Review of the Literature , 2019, Case Reports in Dermatology.

[7]  C. Hermans,et al.  Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature , 2017, Case reports in hematology.

[8]  Hong-Zhong Jin,et al.  Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review , 2017, The Journal of dermatology.

[9]  Y. Kanakura,et al.  Autoimmune bullous disease and Hashimoto's disease complicated by acquired hemophilia A. , 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[10]  R. Srinivasan,et al.  A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70 , 2016, The Journal of experimental medicine.

[11]  A. Pietrzak,et al.  Coexistence of pemphigus foliaceus and acquired hemophilia A: A case report , 2015, The Journal of dermatology.

[12]  D. Zillikens,et al.  Anti-p200 pemphigoid. , 2014, Journal of the American Academy of Dermatology.

[13]  J. Esser,et al.  Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) , 2012, Journal of thrombosis and haemostasis : JTH.

[14]  T. Hashimoto,et al.  Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia , 2008, The Journal of dermatology.

[15]  Jean Kanitakis,et al.  Anti‐laminin 5 pemphigoid and acquired haemophilia , 2002, The British journal of dermatology.